A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Toshiyuki Harada, Masaharu Nishimura, Shunichi Sugawara et al.|The Oncologist|2013Cited by 14
Prospective Multicenter Study of Chemotherapy-Induced Clostridium (Clostridioides) difficile Infection in Patients With Lung Cancer: North Japan Lung Cancer Study Group Trial 1204Yukihiro Toi, Shunichi Sugawara, Takao Kobayashi et al.|Frontiers in Oncology|2021Cited by 7
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302Yosuke Kawashima, Shunichi Sugawara, Akira Inoue et al.|International Journal of Clinical Oncology|2020Cited by 4